Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Expenses (2020 - 2025)

BioAtla (BCAB) has disclosed Accumulated Expenses for 6 consecutive years, with $37000.0 as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 98.64% year-over-year to $37000.0; the TTM value through Dec 2025 reached $37000.0, down 98.64%, while the annual FY2025 figure was $37000.0, 98.64% down from the prior year.
  • Accumulated Expenses hit $37000.0 in Q4 2025 for BioAtla, down from $2.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.8 million in Q4 2023 and bottomed at $37000.0 in Q4 2025.
  • Average Accumulated Expenses over 5 years is $2.1 million, with a median of $2.2 million recorded in 2021.
  • Year-over-year, Accumulated Expenses grew 29.2% in 2022 and then plummeted 98.64% in 2025.
  • BioAtla's Accumulated Expenses stood at $2.7 million in 2021, then rose by 29.2% to $3.5 million in 2022, then rose by 9.82% to $3.8 million in 2023, then fell by 28.07% to $2.7 million in 2024, then tumbled by 98.64% to $37000.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $37000.0, $2.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.